Pharmaceutical Executive Digest Europe - January 28, 2009 - (Page 12) Critical Vision Calendar of the day. Instead they round up the companies that are possible targets and endlessly speculate about what a Pfizer-Amgen, a Pfizer-Gilead Sciences, a Pfizer Bristol-Myers Squibb, or Pfizer-Wyeth might look like and how it might perform. Win Initiative/Getty Images Who knows what Pfizer will do? It looks increasingly likely it will buy itself out of trouble if only because it can. But the arguably more interesting comments about what Pfizer should do come from the blogs, where you find vast numbers of former employees with time on their hands, insider knowledge about the company and nothing to lose by speaking their minds. Since the January announcements that Pfizer would cut up to 800 research jobs by the end of the year and that another 2400 sales reps and managers are threatened with redundancy, comments from these often disgruntled folk have also been in overdrive. Unsurprisingly, and at the risk of oversimplifying the situation, they blame top management for decisions that have come too late (not buying Amgen when it was trading at around $40 in March 2008 rather than now when the price has soared to around $55, for example), for getting rid of older people with all the experience and who do all the work, for not doing nearly enough to dismantle the bureaucracy and for not recognising the company is still too big and would be better off breaking itself down rather than bloating itself further with a large merger. Who knows what Pfizer will do? It looks increasingly likely it will buy itself out of trouble if only because it can. In that sense it is eminently normal. Who in their right minds likes to admit failure and start dismantling what once worked so very well? World Health Care Congress Europe 2009 13-14 May Brussels, Belgium The 5th Annual World Health Care Congress Europe presents business cases, best practices and strategies for addressing the pressures and current challenges facing European health care - efficiency, economic stability, access to care, quality care, patient safety and patient mobility within and across borders. Phone: +1 603 472 7494 www.worldcongress.com/europe DIA EuroMeeting 2009 23-25 March Berlin, Germany The many cultural flavours and facets of Europe provide a contrasting perspective to the global drug market. Often aspects of Europe are not fully understood by colleagues around the world and the EuroMeeting provides a “once-a-year opportunity to explain all.” Phone: +41 61 225 5151 www.diahome.org Fax: +41 61 225 5152 13 CALENDAR Upcoming pharma industry events Medioimages/Photodisc/Getty Images 2 NEWS Teva and Lonza join forces 3 FROM THE EDITOR Crises of confidence 5 2009 FORECAST Why US pharma experts are still optimistic http://www.worldcongress.com/europe http://www.diahome.org
Table of Contents Feed for the Digital Edition of Pharmaceutical Executive Digest Europe - January 28, 2009 Pharmaceutical Executive Digest Europe - January 28, 2009 Contents News From the Editor 2009 Forecast Strategy Jacky Law Calendar Pharmaceutical Executive Digest Europe - January 28, 2009 Pharmaceutical Executive Digest Europe - January 28, 2009 - Contents (Page 1) Pharmaceutical Executive Digest Europe - January 28, 2009 - News (Page 2) Pharmaceutical Executive Digest Europe - January 28, 2009 - From the Editor (Page 3) Pharmaceutical Executive Digest Europe - January 28, 2009 - From the Editor (Page 4) Pharmaceutical Executive Digest Europe - January 28, 2009 - 2009 Forecast (Page 5) Pharmaceutical Executive Digest Europe - January 28, 2009 - 2009 Forecast (Page 6) Pharmaceutical Executive Digest Europe - January 28, 2009 - 2009 Forecast (Page 7) Pharmaceutical Executive Digest Europe - January 28, 2009 - Strategy (Page 8) Pharmaceutical Executive Digest Europe - January 28, 2009 - Strategy (Page 9) Pharmaceutical Executive Digest Europe - January 28, 2009 - Strategy (Page 10) Pharmaceutical Executive Digest Europe - January 28, 2009 - Jacky Law (Page 11) Pharmaceutical Executive Digest Europe - January 28, 2009 - Jacky Law (Page 12) Pharmaceutical Executive Digest Europe - January 28, 2009 - Calendar (Page 13)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.